Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                News & Events

News & Events

                        


                        FDA Meetings, Conferences and Workshops
          OTP Events, Meetings, and Workshops
          Rumor Control
          Approvals of FDA-Regulated Products
          Congressional Testimony
          FDA Newsroom
          Interactive and Social Media
          Public Health Focus
          Speeches by FDA Officials Home
          News & Events
          Annual Patient Engagement & Regenerative Medicine Meeting 2022: An FDA CBER Workshop for Patient Advocates - 05/24/2022News & Events Workshop
    Event Title
              Annual Patient Engagement & Regenerative Medicine Meeting 2022: An FDA CBER Workshop for Patient Advocates


                  May 24, 2022

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting Information
                Event MaterialsDate:
          
  


     
           

May 24, 2022

 

  The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) hosted a public workshop on **Tuesday, May 24, 2022, from 11:00 a.m. - 3:00 p.m. ET.**

The meeting brought together patients, caregivers, advocates, and other important stakeholders to discuss the purpose and importance of natural history studies. FDA staff and panelists discussed how natural history studies contribute to improved understanding of diseases and drug development, including regenerative medicine treatments such as gene and cell therapies.

Natural history studies follow a group of patients over time to collect health information on a particular disease. These studies can play an invaluable role in facilitating greater understanding of diseases and help to inform clinical trial design.

Learn more about FDA’s commitment to natural history studies.

Promotional graphic to promote the Annual Patient Engagement and Regenerative Medicine Workshop: An FDA CBER Workshop for Patient Advocates on May 24, 2022 from 11:00 a.m. – 3:00 p.m. ET. Attendees will learn how natural history studies help shape the future of regenerative medicine.
About the Workshop

This workshop was the second annual patient engagement meeting hosted by FDA CBER OTAT.

The workshop featured a variety of speakers and panelists to discuss:

Natural history studies and why they are important for the development of regenerative medicine therapies.
	Perspectives from patients and advocates with firsthand experience participating in natural history studies.
	Opportunities for patients, advocates, and other important stakeholders to get involved in natural history studies and help advance clinical research for gene and cell therapies.
	How organizations, including FDA, support natural history studies.
	Opportunities to engage directly with CBER and others at FDA.Recording

Zoom Webinar  Recording for Annual Patient Engagement & Regenerative Medicine Meeting 2022: An FDA CBER Workshop for Patient AdvocatesWhat Is Regenerative Medicine?

Regenerative medicine therapies, such as gene and cell therapies, hold promise to transform medicine and create treatment options for patients who are living with difficult, even incurable diseases. The FDA plays a vital role in facilitating the development of regenerative medicine therapies and is committed to helping speed development of these groundbreaking treatments.

About the RegenMedEd Event Series

This workshop is part of OTAT’s educational webinar series, RegenMedEd, which engages patients, caregivers, and advocates on the topic of regenerative medicine. The RegenMedEd series aims to bring together patients, caregivers, patient advocates, and FDA staff to discuss foundational information about regenerative medicine therapies, such as gene therapy and cell therapy, and explore opportunities for stakeholders to engage with FDA to help advance drug development.





Event Materials

  Title
            File Type/SizeAnnual Patient Engagement & Regenerative Medicine Meeting: An FDA CBER Workshop for Patient Advocates - Slide Deck
              pdf               (10.70 MB)Annual Patient Engagement & Regenerative Medicine Meeting 2022: An FDA CBER Workshop for Patient Advocates - Transcript
              pdf               (480.98 KB)

                                                                                  Content current as of:
      07/22/2022
         
                   
Regulated Product(s)
		 BiologicsMore Meetings,
      Conferences, and
      Workshops
        
        News & Events

          
                        


                        FDA Meetings, Conferences and Workshops
          OTP Events, Meetings, and Workshops
          Rumor Control
          Approvals of FDA-Regulated Products
          Congressional Testimony
          FDA Newsroom
          Interactive and Social Media
          Public Health Focus
          Speeches by FDA Officials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop